Gene · 10801
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Septins buffer actomyosin forces to protect the nucleus from genotoxic mechanical stress. | bioRxiv | 2026 | 41648557 | PubTator, text mining | PubMed |
| Allelic Variation at 9p21.3 Orchestrates Widespread RNA Splicing Shifts Governing Vascular Smooth Muscle Cell Plasticity. | bioRxiv | 2026 | 41648216 | PubTator, text mining | PubMed |
| Active-site rich nanostructure with dual-enhanced electron transfer for ultra-sensitive electrochemiluminescence detection of DNA methylation in colon cancer. | Biosens Bioelectron | 2026 | 41643420 | PubTator, text mining | PubMed |
| Multi-gene DNA methylation profiles of tumor suppressor genes for prognostic prediction in gastric cancer. | BMC Cancer | 2026 | 41634637 | PubTator, text mining | PubMed |
| The expression profiling of serum circPHLPP2 and LncRNA ILF3 in colorectal cancer patients. | Sci Rep | 2026 | 41620490 | PubTator, text mining | PubMed |
| Genome-wide extraction of differentially methylated DNA regions using adapter-anchored proximity primers. | Nucleic Acids Res | 2026 | 41614298 | PubTator, text mining | PubMed |
| Diagnostic performance of multimodal biomarkers in colorectal cancer. | Sci Rep | 2026 | 41593340 | PubTator, text mining | PubMed |
Collaborative breakthroughs in precision diagnosis and treatment of nasopharyngeal cancer: Biomarker‑driven screening and endoscopic minimally invasive surgery reshape the new paradigm of early intervention (Review). | Oncol Rep | 2026 | 41574726 | PubTator, text mining | PubMed |
| Stool DNA-based SDC2 Methylation Test for the Screening of Colorectal Neoplasia in an Asymptomatic, Average-Risk Population. | Korean J Gastroenterol | 2026 | 41572658 | PubTator, text mining | PubMed |
| Methionine restriction for cancer therapy: From preclinical studies to clinical trials. | Cancer Pathog Ther | 2026 | 41550357 | PubTator, text mining | PubMed |
| Synergistic CRISPR/Cas12a-Nanozyme System for Iontronic Sensing of Site-Specific Septin9 Methylation. | Anal Chem | 2026 | 41548240 | PubTator, text mining | PubMed |
| Epigenetic alterations in rotator cuff tendinopathy and degenerative cuff tears: a systematic review. | JSES Rev Rep Tech | 2026 | 41536319 | PubTator, text mining | PubMed |
| SEPT9 as a therapeutic target for enhancing radiotherapy efficacy in esophageal squamous cell carcinoma. | Discov Oncol | 2026 | 41484756 | PubTator, text mining | PubMed |
| Development of a circulating tumor DNA methylation biomarker panel for hepatocellular carcinoma detection. | Eur J Surg Oncol | 2026 | 41273828 | PubTator, text mining | PubMed |
| Validation of Liquid Biopsy Using a Methylated SEPT9 Assay and Integrated Index for Detecting Hepatocellular Carcinoma. | Hepatol Res | 2026 | 41250999 | PubTator, text mining | PubMed |
| Epigenetic changes associated with severe necrosis and survival in preterm infants with surgical necrotizing enterocolitis. | Pediatr Res | 2026 | 40987827 | PubTator, text mining | PubMed |
| Diagnostic value of multi-gene methylation in colorectal cancer screening. | Front Oncol | 2025 | 41584609 | PubTator, text mining | PubMed |
| [Performance of Plasma Multigene Methylation Testing in Early Diagnosis of Colorectal Cancer]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536651 | PubTator, text mining | PubMed |
| Stool- and Blood-Associated Colorectal Cancer Biomarkers: A Systematic Review. | Cancers (Basel) | 2025 | 41514609 | PubTator, text mining | PubMed |
| Diagnostic and prognostic value of polygene methylation detection in ascites. | Front Genet | 2025 | 41477641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10801/papers?page=4